Safety of Adjuvanted Recombinant Herpes Zoster Virus Vaccination in Fragile Populations: An Observational Real-Life Study

Background: Vaccination is the most effective strategy for preventing infectious diseases and related complications, and proving its efficacy is crucial for its success and adherence, especially for newly introduced vaccines, such as adjuvanted recombinant herpes zoster virus vaccination (RZV). In t...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Maria Costantino, Valentina Giudice, Giuseppina Moccia, Walter Longanella, Simona Caruccio, Giuliana Tremiterra, Pio Sinopoli, David Benvenuto, Bianca Serio, Francesca Malatesta, Nadia Pecoraro, Emilia Anna Vozzella, Riccardo Rossiello, Giovanni Genovese, Francesco De Caro
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	MDPI AG 2024-08-01
Saila:	Vaccines
Gaiak:	AEFI herpes zoster vaccine hesitancy vaccination
Sarrera elektronikoa:	https://www.mdpi.com/2076-393X/12/9/990
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!